1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

02 Sep 2022
Admin
News Article

Covaxin Approved For Emergency Use In 13 Countries Mos For Health Bharati Pravin Pawar

Covaxin Has Been Granted Approval For Emergency Use In 13 Countries As Of January 31, 2022, According To The Who, Said Minister Of State (Mos) For Health Bharati Pravin Pawar In Lok Sabha On February 4.Covaxin Has Been Granted Approval For Emergency Use In 13 Countries As Of January 31, 2022, According To The Who, Said Minister Of State (Mos) For Health Bharati Pravin Pawar In Lok Sabha On February 4. Giving The Details About Covaxin, The Mos For Health Said, "Covaxin Has Been Granted Emergency Use Listing (Eul) By National Regulator Drug Controller General Of India (Dcg(I)) In The Age-Group From 12 To 18 Years On 24Th December 2021."In Her Written Reply, She Mentioned That The Covid-19 Working Group Of National Technical Advisory Group On Immunisation (Ntagi) Recommended Covid-19 Vaccination In Adolescents Aged 15 Years To Less Than 18 Years. "On The Recommendation Of Covid-19 Working Group And Standing Technical Subcommittee Of National Technical Advisory Group On Immunization (Ntagi), Government Of India Has Started Vaccination Of Adolescents Aged 15 Years To Less Than 18 Years From 3Rd January 2022," She Informed The Lok Sabha. She Said That The Grant Of Approval To A Vaccine By Any Country Is A Technical And Scientific Process For Which Data Is To Be Submitted To The Regulator By The Vaccine Manufacturer As Per The Prescribed Rules. Regarding Supplies, She Said That No Specific Information Has Been Brought To Notice By Foreign Companies That They Are Facing Difficulties In The Supply Of Covaxin. "During The Second Surge Of Covid Cases In April, May 2021 In The Country, The Requirements Of National Covid-19 Vaccination Programme Were Prioritized. This May Have Impacted Foreign Commercial Contracts Entered Into By Domestic Vaccine Manufacturers. As Informed By The Ministry Of External Affairs, There Is No Financial Loss Involved Since During The Second Surge Of Covid Pandemic In The Country, Domestic Vaccine Production Was Procured And Utilized In The National Covid-19 Vaccination Programme," She Added. (Ani)

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!